In Vitro Activities of the New Antifungal Drug Eberconazole and Three Other Topical Agents against 200 Strains of Dermatophytes

AUTOR(ES)

Fernández-Torres, Belkys

FONTE

American Society for Microbiology

RESUMO

We have compared the in vitro activity of the new antifungal drug eberconazole with those of three other topical antifungal agents, clotrimazole, ketoconazole, and miconazole, against 200 strains of dermatophytes. MICs were determined by a microdilution method with optimal conditions determined in a previous study (an inoculum of 104 CFU/ml, an incubation temperature of 28°C, an incubation period of 7 days, and a MIC endpoint of 100% inhibition of growth). In general, the four drugs tested showed low MICs. However, eberconazole was more active (P < 0.05) than the other three drugs against the majority of the species tested. Eberconazole represents an advantageous alternative for dermatophytoses where a topical therapy is required.

Documentos Relacionados

• In Vitro Activities of Voriconazole in Combination with Three Other Antifungal Agents against Candida glabrata
• In Vitro Activities of New Antifungal Agents against Chaetomium spp. and Inoculum Standardization
• In Vitro Activities of New and Conventional Antifungal Agents against Clinical Scedosporium Isolates
• In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp.
• Comparison of In Vitro Activities of Voriconazole and Five Established Antifungal Agents against Different Species of Dermatophytes Using a Broth Macrodilution Method